These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 187001

  • 1. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC, Chew SC, Ratnam SS.
    Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
    [Abstract] [Full Text] [Related]

  • 2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunoassay of serum chorionic gonadotropin and placental lactogen in trophoblastic disease.
    Yen SS, Pearson OH, Rankin JS.
    Obstet Gynecol; 1968 Jul; 32(1):86-93. PubMed ID: 4316070
    [No Abstract] [Full Text] [Related]

  • 4. Study on the systematic use of serial estimation of human placental lactogen (hPL) and human chorionic gonadotropin (hCG) for the management of trophoblastic neoplasia.
    Chough SY.
    Endocrinol Jpn; 1973 Feb; 20(1):9-21. PubMed ID: 4353253
    [No Abstract] [Full Text] [Related]

  • 5. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 7. Hydatidiform mole combined with fetus: extended diagnostic arsenal.
    DeFoort P, Dhont M, Thiery M.
    Am J Obstet Gynecol; 1976 Dec 15; 126(8):1049-51. PubMed ID: 998685
    [No Abstract] [Full Text] [Related]

  • 8. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY, Teoh ES.
    Obstet Gynecol; 1976 Feb 15; 47(2):183-8. PubMed ID: 1250540
    [Abstract] [Full Text] [Related]

  • 9. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov 15; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract] [Full Text] [Related]

  • 10. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M, Hussa R, Pattillo R, Boime I.
    J Cell Biol; 1983 Oct 15; 97(4):1200-6. PubMed ID: 6619191
    [Abstract] [Full Text] [Related]

  • 11. Comparative assay of HCG, HCT and HCS in molar pregnancy.
    Tojo S, Mochizuki M, Kanazawa S.
    Acta Obstet Gynecol Scand; 1974 Oct 15; 53(4):369-73. PubMed ID: 4474790
    [Abstract] [Full Text] [Related]

  • 12. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 15; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 13. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP.
    Am J Obstet Gynecol; 1971 Jun 15; 110(4):583-7. PubMed ID: 4325820
    [No Abstract] [Full Text] [Related]

  • 14. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 15; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 16. [Regression of hCG in various types of molar pregnancies--clinical course and prognosis].
    Rob L, Robová H, Pluta M, Kulovaný E, Hrehorcák M, Chmel R, Schlegerová D, Kodet R, Macek M.
    Ceska Gynekol; 2001 Jul 15; 66(4):230-5. PubMed ID: 11569415
    [Abstract] [Full Text] [Related]

  • 17. [Trophoblastic disease. I. Use of immunohistochemistry in the diagnosis of complete hydatidiform moles].
    Danihel L, Porubský J, Zaviacic T, Vojtassák J, Breitenecker G.
    Cesk Patol; 1994 Aug 15; 30(3):76-9. PubMed ID: 7923420
    [Abstract] [Full Text] [Related]

  • 18. In vitro biosynthesis of human placental lactogen (HPL) by chorionic tissue and the diagnostic value of HPL in trophoblastic disease.
    Sato Y.
    Endocrinol Jpn; 1973 Jun 15; 20(3):291-306. PubMed ID: 4357807
    [No Abstract] [Full Text] [Related]

  • 19. Immunocytochemical localization of chorionic gonadotropin, placental lactogen, and placental alkaline phosphatase in the diagnosis of complete and partial hydatidiform moles.
    Brescia RJ, Kurman RJ, Main CS, Surti U, Szulman AE.
    Int J Gynecol Pathol; 1987 Jun 15; 6(3):213-29. PubMed ID: 3429106
    [Abstract] [Full Text] [Related]

  • 20. [Molar pregnancy (primary or recurrent?)].
    Ayala A, Aizpuru E, Tovar JM.
    Ginecol Obstet Mex; 1989 Aug 15; 57():226-8. PubMed ID: 2562106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.